Identifying Heart, Lung, and Blood Disease-Causing Variants

by: TopGovernmentGrants Editorial Staff

The National Institutes of Health, otherwise known as NIH, is the agency operating within the United States Department of Health and Human Services that is fundamentally responsible for all of the country's biomedical and health-related research studies.

The programs and objectives of the NIH are tailored to contribute to the achievement of their agency mission, which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In keeping with this mission, the National Institutes of Health has formed a partnership with the National Heart, Lung, and Blood Institute to establish a program that aims to Identify Heart, Lung, and Blood Disease-Causing Variants.

The Identifying Heart, Lung, and Blood Disease-Causing Variants Program aims to follow suit to research studies that intend to identify heart, lung, and blood disease-causing rare or lower frequency variants through the use of the extensive exome data that was discovered under the Recovery and Reinvestment Act of 2009.

The organizers of the program believe that this data will enable lung, heart and blood investigators, to focus on variants, genes, and pathways that could potentially lead them to a deeper and more thorough understanding of certain complex diseases.

  (continued...)

Identifying Heart, Lung, and Blood Disease-Causing Variants
  Page 2

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Harnessing Advanced Health Technologies to Drive Mental Health Improvement Program
The National Institutes of Health has collaborated with National Institute of Mental Health (NIMH) in order to constitute the establishment of the Harnessing Advanced Health Technologies to Drive Mental Health Improvement Program.

---

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---

HRSA: Reducing Loss to Follow-up after Failure to Pass Newborn Hearing Screening
Reducing to Loss of Follow-up after Failure to Pass Newborn Hearing Screening program enables eligible health care institutions to solicit funds by establishing project proposals that would greatly improve the number of infants receiving appropriate and timely follow-ups through the utilization of patient-centered interventions.

---

Biodemography of Aging Program
The National Institutes of Health has formed a partnership with the National Institute on Aging (NIA) in an effort to establish the Biodemography of Aging Program wherein they intend to solicit applications with the intent to conduct research studies regarding demographic and life-science approaches that could potentially expand the current understanding of aging, frailty and mortality.

---